References
- Abdul AH, Sreeramulu J, Padmaja BS, et al. Preparation of Fluconazole – β Cyclodextrin Complex Ocuserts: In vitro and In vivo Evaluation. ISRN Pharmaceutics. 2011; 8(1): 1–8.
- Bakheit AH, Alomar AM, Darwish H, et al. Brimonidine. Profiles Drug Subst Excip Relat Methodol. 2023; 48: 1–37.
- Bhabani SN, Ch S, Patnaik RA, et al. Formulation Design and In vitro-In vivo Evaluation of Moxifloxacin Ophthalmic Insert. Am. J. Phtyomedicine Clin. ther. 2015; 3(4): 24–31.
- Das S, Behera A, Habibullah S et al. Moxifloxacin-loaded PVA-chitosan composite films as potential ocular drug delivery systems: A comprehensive characterization and efficacy assessment. Int J Biol Macromol. 2025; 29(6): 139726.
- Devhadrao N, Siddhaia M. Review on ocular insert drug delivery system. J. of Drug Del. and Therapeutics. 2018; 8(5): 115–21.
- Dubashynskaya N, Poshina D, Raik S, et al. Polysaccharides in Ocular Drug Delivery. Pharmaceutics. 2022 Jun 6; 12(1): 22.
- Farahmandnejad M, Alipour S, Nokhodchi A. Physical and mechanical properties of ocular thin films: a systematic review and meta-analysis. Drug Discov Today. 2024; 29(5): 103964.
- Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin. Drug Delivery. 2010; 7(4): 429–44.
- Gu D, Zhou L, Zhang Y, et al. N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome. Int J Biol Macromol. 2025; 2(1): 140123.
- Hady MA, El-Zahaby SA. Phospholipid Free Nano-Vesicles of Brinzolamide Biopolymer Ocular Insert; Design, In vitro and In vivo Evaluation. J Pharm Sci. 2024: 2(2): 64–9.
- Hu T, Zhou T, Goit RK, et al. Bioactive Glial-Derived Neurotrophic Factor from a Safe Injectable Collagen-Alginate Composite Gel Rescues Retinal Photoreceptors from Retinal Degeneration in Rabbits. Mar Drugs. 2024; 22(9): 394–409.
- Huang S, Xu Y, Luo Y, et al. Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration. Pharmaceutics. 2024; 16(12): 1496.
- Jayaram H, Kolko M, Friedman DS, et al. Glaucoma: Now and beyond. The Lancet. 2023; 402: 1788–801.
- Kavitha S, Tejaswini SU, Venkatesh R, et al. Wound modulation in glaucoma surgery: The role of anti-scarring agents. Indian J. Ophthalmol. 2024; 72(3): 320–27.
- Kleinman D, Iqbal S, Ghosh AK, et al. PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In vitro. J Ocul Pharmacol Ther. 2024; 40(7): 419–427.
- Koutsoviti M, Siamidi A, Pavlou P, et al. Recent Advances in the Excipients Used for Modified Ocular Drug Delivery. Materials. 2021; 14(15): 4290–9.
- Kumar K, Faeek M, Parveen N. Preparation and Evaluation of Ocuserts for Increasing the Bioavailability of an Antifungal Drugs. Acta Scientific Pharma Sci. 2022; 18(7): 17–23.
- Lazcano-Gomez G, Ramos-Cadena MLA, Torres-Tamayo M, Het al., Cost of glaucoma treatment in a developing country over a 5-year period. Medicine (Baltimore). 2016; 95(47): 41–53.
- Lu G, Li B, Lin L, et al. Mechanical strength affecting the penetration in microneedles and PLGA nanoparticle-assisted drug delivery: Importance of preparation and formulation. Biomed. Pharmacother. 2024; 17(3): 116–39.
- Mahajan HS, Deshmukh SR. Development and evaluation of gel-forming ocular films based on xyloglucan. Carbohydrate Polymers. 2015; 12(2): 243–7.
- Matthews BR, Wall GM. Stability Storage and Testing of Ophthalmic Products for Global Registration. Drug Dev Ind Pharm. 2000; 26(12): 1227–37.
- Mealy JE, Fedorchak MV, Little SR. In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate. Acta Biomaterialia. 2014; 10(1): 87–93.
- Nagpal N, Singh S, Kaur G, et al. Formulation and evaluation of controlled release ocusert of gatifloxacin and prednisolone. Acta Marisiensis - Seria Medica. 2021; 67(4): 227–37.
- Nair RV, Suresh A, Nair SC. Sustained release timolol maleate loaded ocusert based on biopolymer composite. Int J Biol Macromol. 2018; 11(1): 308–17.
- Navneet N, Sukhmanpreet S, Prince AM, et al. Ocuserts: A novel ocular-drug delivery method: An update. World J. of Bio Pharmacy and Health Sci. 2023; 13(1): 470–7.
- Paganini V, Chetoni P, Gangi M, et al. Nanomicellar eye drops: a review of recent advances. Expert Opin. Drug Delivery. 2024; 21(3): 381–97.
- Parastoo T, Soltani S, Seyed HM, et al. Formulation of Tolmetin Ocuserts As Carriers for Ocular Drug Delivery System. Iran J Pharm Res. 2017; 16(2): 432–41.
- Rahbar N, Darvish S, Farrahi F, et al. Chitosan/carbomer nanoparticles-laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study. Drug Deliv Transl Res. 2024; 1(1): 22–32.
- Rahić O, Tucak A, Omerovic N, et al. Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions. Pharmaceutics. 2020; 13(1): 28.
- Razavi MS, Ebrahimnejad P, Fatahi Y, et al. Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds. Front Chem. 2022; 10(1): 850–57.
- Revathy VN, Sreeja CN. Ocular insert of Timolol Maleate using naturally occurring biodegradable polymer. J Chem Pharm Res. 2015; 7(7): 476–485.
- Sarath C, Shirwaikar A, Devi A. Development and Evaluation of Chitosan Ocuserts Containing Ciprofloxacin -β CD Complex. Int. J. Pharmtech Res. 2010; 2(1): 246–252.
- Sarkar T, Gogoi NR, Jana BK, et al. Formulation Advances in Posterior Segment Ocular Drug Delivery. J Ocul Pharmacol Ther. 2025; 2(1): 7–18.
- Shadambikar G, Marathe S, Patil A, et al. Novel Application of Hot Melt Extrusion Technology for Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts. AAPS PharmSciTech. 2021; 22(1): 48–55.
- Sun J, Zhang X, Huang T. A validated stability-indicating HPLC method for determination of brimonidine tartrate in drug delivery systems. Chem Cent J. 2017; 11(1): 62–72.
- Taghe S, Mirzaeei S, Pakdaman N, et al. Macrolide-loaded nanofibrous inserts with polycaprolactone and cellulose acetate base for sustained ocular delivery: Pharmacokinetic study in Rabbit’s eye. Int J Pharm. 2024; 665: 124699.
- Teba HE, Khalil IA, Gebreel RM, et al. Development of antifungal fibrous ocular insert using freeze-drying technique. Drug Deliv Transl Res. 2024; 10(1): 87–93.
- Tham YC, Li X, Wong TY, et al., Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmol. 2014; 121(11): 2081–90.
- Tundisi LL, Mostaço GB, Carricondo PC, et al. Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations. Eur J Pharm Sci. 2021; 15(9): 105–122.
- Varma R, Lee PP, Goldberg I, et al. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011; 152(4): 515–22.
- Vashist P, Senjam SS, Gupta V, et al. Blindness and visual impairment and their causes in India: Results of a nationally representative survey. PLoS One. 2022; 17(7): 27–36.
- Vecchi CF, Cesar GB, Souza PR, et al. Mucoadhesive polymeric films comprising polyvinyl alcohol, polyvinylpyrrolidone, and poloxamer 407 for pharmaceutical applications. Pharm Dev Technol. 2021; 26(2): 138–149.
- Vijaya L, George R, Baskaran M, et al. Prevalence of primary open angle glaucoma in an urban south Indian population and comparison with a rural population. The Chennai glaucoma study. Ophthalmology. 2008; 115(2): 648–54
- Vijayaraghavan R, Loganathan S, Valapa RB. 3D bioprinted photo crosslinkable GelMA/methylcellulose hydrogel mimicking native corneal model with enhanced in vitro cytocompatibility and sustained keratocyte phenotype for stromal regeneration. Int J Biol Macromol. 2024; 2(1): 130–72.
- Xu H, Liu Y, Jin L, et al. Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery. Pharmaceuticals. 2023; 16(1): 90–110.
- Zhang Y, Huang S, Xie B, Zhong Y. Aging, Cellular Senescence, and Glaucoma. Aging Dis. 2024; 15(2):546–64.
- Zhao T, Jiang X, Hao R, et al. Efficacy of 2% Hydroxypropyl Methylcellulose and Bandage Contact Lens for the Management of Dry Eye Disease after Cataract Surgery. J Ophthalmol. 2024; 20: 8415425.
- Zhi K, Raji B, Nookala AR, et al. PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery. Pharmaceutics. 2021; 13(4): 500–10.